Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aclaris Therapeutics Inc.

www.aclaristx.com

Latest From Aclaris Therapeutics Inc.

Biotech Aclaris Ready For Premium Pricing For Skin Drug A-101

Treating lesions on the face is a very significant opportunity for Aclaris, which is focusing on younger clientele.

Advertising, Marketing & Sales Pricing Strategies

Deals Shaping The Medical Industry, September 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2017.

Deals Medical Device

Finance Watch: Roivant Raises $1.1bn, Relying On Private Equity To Fund New Companies

Roivant will use the cash to fund other "Vants" that develop drugs or make the process more efficient. Also, Zealand launches its IPO, Apellis raises a $60m Series E and BioMarin tops recent offerings.

Financing Business Strategies

Deal Watch: GSK Declines Option As Ionis' Inotersen Nears Finish Line

Ionis will file polyneuropathy candidate in US and EU on its own, while GSK de-emphasizes rare diseases. Aclaris buys Confluence in earn-out-heavy deal, and Galena undertakes reverse merger with Sellas.

Deals M & A
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Aclaris Therapeutics Inc.
  • Senior Management
  • Neal Walker, MD, Pres. & CEO
    Frank Ruffo, CFO & Treasurer
    Stuart D Shanler, MD, CSO
    Christopher Powala, COO
    Brett Fair, SVP, Commercial Operations
    Kevin Scott, VP, Sales
  • Contact Info
  • Aclaris Therapeutics Inc.
    Phone: (484) 324-7933
    101 Lindenwood Dr.
    Ste. 400
    Malvern, PA 19355
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register